207 related articles for article (PubMed ID: 22728334)
21. Phosphorylation of IRS1 at serine 307 in response to insulin in human adipocytes is not likely to be catalyzed by p70 ribosomal S6 kinase.
Rajan MR; Fagerholm S; Jönsson C; Kjølhede P; Turkina MV; Strålfors P
PLoS One; 2013; 8(4):e59725. PubMed ID: 23565163
[TBL] [Abstract][Full Text] [Related]
22. Heparin-binding EGF-like growth factor (HB-EGF) mediates 5-HT-induced insulin resistance through activation of EGF receptor-ERK1/2-mTOR pathway.
Li Q; Hosaka T; Shikama Y; Bando Y; Kosugi C; Kataoka N; Nakaya Y; Funaki M
Endocrinology; 2012 Jan; 153(1):56-68. PubMed ID: 22028447
[TBL] [Abstract][Full Text] [Related]
23. Ceramide-activated protein phosphatase involvement in insulin resistance via Akt, serine/arginine-rich protein 40, and ribonucleic acid splicing in L6 skeletal muscle cells.
Ghosh N; Patel N; Jiang K; Watson JE; Cheng J; Chalfant CE; Cooper DR
Endocrinology; 2007 Mar; 148(3):1359-66. PubMed ID: 17158207
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
Halevy O; Cantley LC
Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
[TBL] [Abstract][Full Text] [Related]
25. Rab5a activates IRS1 to coordinate IGF-AKT-mTOR signaling and myoblast differentiation during muscle regeneration.
Cong XX; Gao XK; Rao XS; Wen J; Liu XC; Shi YP; He MY; Shen WL; Shen Y; Ouyang H; Hu P; Low BC; Meng ZX; Ke YH; Zheng MZ; Lu LR; Liang YH; Zheng LL; Zhou YT
Cell Death Differ; 2020 Aug; 27(8):2344-2362. PubMed ID: 32051546
[TBL] [Abstract][Full Text] [Related]
26. The reciprocal stability of FOXO1 and IRS2 creates a regulatory circuit that controls insulin signaling.
Guo S; Dunn SL; White MF
Mol Endocrinol; 2006 Dec; 20(12):3389-99. PubMed ID: 16916938
[TBL] [Abstract][Full Text] [Related]
27. The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance.
Carvalheira JB; Calegari VC; Zecchin HG; Nadruz W; Guimarães RB; Ribeiro EB; Franchini KG; Velloso LA; Saad MJ
Endocrinology; 2003 Dec; 144(12):5604-14. PubMed ID: 12960006
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of insulin receptor substrate 1 reduces proliferation and downregulates Akt/mTOR and MAPK pathways in K562 cells.
Machado-Neto JA; Favaro P; Lazarini M; Costa FF; Olalla Saad ST; Traina F
Biochim Biophys Acta; 2011 Aug; 1813(8):1404-11. PubMed ID: 21569802
[TBL] [Abstract][Full Text] [Related]
29. Involvement of mTOR in Type 2 CRF Receptor Inhibition of Insulin Signaling in Muscle Cells.
Chao H; Li H; Grande R; Lira V; Yan Z; Harris TE; Li C
Mol Endocrinol; 2015 Jun; 29(6):831-41. PubMed ID: 25875045
[TBL] [Abstract][Full Text] [Related]
30. Myosin phosphatase and myosin phosphorylation in differentiating C2C12 cells.
Wu Y; Erdodi F; Murányi A; Nullmeyer KD; Lynch RM; Hartshorne DJ
J Muscle Res Cell Motil; 2003; 24(8):499-511. PubMed ID: 14870965
[TBL] [Abstract][Full Text] [Related]
31. Regulation of IRS1/Akt insulin signaling by microRNA-128a during myogenesis.
Motohashi N; Alexander MS; Shimizu-Motohashi Y; Myers JA; Kawahara G; Kunkel LM
J Cell Sci; 2013 Jun; 126(Pt 12):2678-91. PubMed ID: 23606743
[TBL] [Abstract][Full Text] [Related]
32. Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6 muscle cells.
Pirola L; Bonnafous S; Johnston AM; Chaussade C; Portis F; Van Obberghen E
J Biol Chem; 2003 May; 278(18):15641-51. PubMed ID: 12594228
[TBL] [Abstract][Full Text] [Related]
33. Effect of testosterone on insulin stimulated IRS1 Ser phosphorylation in primary rat myotubes--a potential model for PCOS-related insulin resistance.
Allemand MC; Irving BA; Asmann YW; Klaus KA; Tatpati L; Coddington CC; Nair KS
PLoS One; 2009; 4(1):e4274. PubMed ID: 19169352
[TBL] [Abstract][Full Text] [Related]
34. Effect of tumor necrosis factor-alpha on insulin-stimulated mitogen-activated protein kinase cascade in cultured rat skeletal muscle cells.
Begum N; Ragolia L; Srinivasan M
Eur J Biochem; 1996 May; 238(1):214-20. PubMed ID: 8665940
[TBL] [Abstract][Full Text] [Related]
35. Zinc stimulates glucose consumption by modulating the insulin signaling pathway in L6 myotubes: essential roles of Akt-GLUT4, GSK3β and mTOR-S6K1.
Wu Y; Lu H; Yang H; Li C; Sang Q; Liu X; Liu Y; Wang Y; Sun Z
J Nutr Biochem; 2016 Aug; 34():126-35. PubMed ID: 27295130
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms by which smoothelin-like protein 1 reverses insulin resistance in myotubules and mice.
Tamas I; Major E; Horvath D; Keller I; Ungvari A; Haystead TA; MacDonald JA; Lontay B
Mol Cell Endocrinol; 2022 Jul; 551():111663. PubMed ID: 35508278
[TBL] [Abstract][Full Text] [Related]
37. PAQR3 modulates insulin signaling by shunting phosphoinositide 3-kinase p110α to the Golgi apparatus.
Wang X; Wang L; Zhu L; Pan Y; Xiao F; Liu W; Wang Z; Guo F; Liu Y; Thomas WG; Chen Y
Diabetes; 2013 Feb; 62(2):444-56. PubMed ID: 23086038
[TBL] [Abstract][Full Text] [Related]
38. Liraglutide ameliorates palmitate-induced insulin resistance through inhibiting the IRS-1 serine phosphorylation in mouse skeletal muscle cells.
Li Z; Zhu Y; Li C; Tang Y; Jiang Z; Yang M; Ni CL; Li D; Chen L; Niu W
J Endocrinol Invest; 2018 Sep; 41(9):1097-1102. PubMed ID: 29374854
[TBL] [Abstract][Full Text] [Related]
39. The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1δ.
Grassie ME; Moffat LD; Walsh MP; MacDonald JA
Arch Biochem Biophys; 2011 Jun; 510(2):147-59. PubMed ID: 21291858
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory cross-talk between the AMPK and ERK pathways mediates endoplasmic reticulum stress-induced insulin resistance in skeletal muscle.
Hwang SL; Jeong YT; Li X; Kim YD; Lu Y; Chang YC; Lee IK; Chang HW
Br J Pharmacol; 2013 May; 169(1):69-81. PubMed ID: 23373714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
